Improved Long-Term Survival Following Myocardial Infarction With Fibrinolytic Therapy

Abstract

Intravenous fibrinolytic therapy has no significant advantage over anticoagulants upon the immediate mortality associated with recent myocardial infarction. Fibrinolytic and anticoagulant agents reduced the immediate mortality of patients with recent myocardial infarction compared to control patients. An improved long-term mortality was noted in patients with myocardial infarction who were treated with Thromboly-sin (fibrinolysin) within 20 hr. after onset of chest pain.